The Affiliated Hospital Of Hangzhou Normal University
Clinical trials sponsored by The Affiliated Hospital Of Hangzhou Normal University, explained in plain language.
-
Zapping the brain to heal the liver: new trial tests rTMS for MetALD
Disease control Not yet recruitingThis study tests whether a non-invasive brain stimulation technique called rTMS can reduce liver fat in people with Metabolic dysfunction-associated and alcohol-related liver disease (MetALD). 105 participants will receive either personalized rTMS, standard rTMS, or a sham (place…
Phase: NA • Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Disease control
Last updated May 26, 2026 10:56 UTC
-
20,000 seniors join quest to unlock fatty liver mysteries
Knowledge-focused Not yet recruitingThis study will follow 20,000 elderly people (age 65+) with fatty liver disease to learn what lifestyle, environmental, and genetic factors affect their condition. Researchers aim to build a health risk assessment system for liver scarring, heart problems, and muscle loss. The go…
Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC